IQSM:NYE-Iq Candriam ESG U.S. Mid Cap Equity ETF (USD)

ETF | Others |

Last Closing

USD 30.0682

Change

-0.15 (-0.50)%

Market Cap

USD 0.20B

Volume

465.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-05 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE Southern Company (The) Series ..

-0.16 (-0.72%)

USD 65.72B
JEPI JPMorgan Equity Premium Income..

+0.24 (+0.41%)

USD 35.71B
DFAC Dimensional U.S. Core Equity 2..

+0.35 (+1.03%)

USD 31.07B
DTB DTE Energy Company 2020 Series

-0.10 (-0.47%)

USD 26.58B
JPST JPMorgan Ultra-Short Income ET..

-0.04 (-0.08%)

USD 25.99B
SGOV iShares® 0-3 Month Treasury B..

+0.04 (+0.04%)

USD 25.64B
GBTC Grayscale Bitcoin Trust (BTC)

+1.10 (+2.26%)

USD 23.75B
AVUV Avantis® U.S. Small Cap Value..

+1.41 (+1.49%)

USD 13.60B
JAAA Janus Detroit Street Trust - J..

+0.02 (+0.04%)

USD 12.46B
DFUV Dimensional US Marketwide Valu..

+0.53 (+1.28%)

USD 11.30B

ETFs Containing IQSM

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.15% 30% F 39% F
Dividend Return 0.54% 16% F 12% F
Total Return 0.39% 21% F 33% F
Trailing 12 Months  
Capital Gain 6.99% 48% F 53% F
Dividend Return 0.87% 14% F 10% F
Total Return 7.87% 40% F 46% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 4.03% 74% C 56% F
Dividend Return 4.31% 71% C- 48% F
Total Return 0.28% 18% F 7% C-
Risk Return Profile  
Volatility (Standard Deviation) 7.01% 63% D 84% B
Risk Adjusted Return 61.53% 79% B- 81% B-
Market Capitalization 0.20B 74% C 33% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.